TheraRadar
← Back
Data updated: Mar 29, 2026

PRAXGEN

Infectious DiseaseOncology
Generics

PRAXGEN is a generic drug manufacturer focused on Infectious Disease, Oncology.

2019
Since
4
Drugs
-
Trials
104
Approved (2yr)

Key Drugs

No active drugs

Top Drug Revenues Pro

Loading...

Revenue Over Time Pro

Loading...

Recent Activity

DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
DOXYCYCLINE HYCLATE 2025-12-09
SEC Filings Pro
Loading...

Therapeutic Areas

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Infectious Disease 50%
1 drugs
Oncology 50%
1 drugs

Pipeline Forecast

Loading...

Upcoming Trial Milestones Pro

Loading...

Patent Cliff Pro

Loading...

Competitors by Therapeutic Area

Pfizer big-pharma
Oncology, Infectious Disease
Merck big-pharma
Oncology, Infectious Disease
Baxter specialty
Infectious Disease, Oncology
AbbVie big-pharma
Oncology, Infectious Disease
Johnson & Johnson big-pharma
Oncology, Infectious Disease